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Tamaka Shwasa is Kapha-Vataja Vikara and the site 
of origin is Pittasthana. The causative factors 
responsible for Tamaka Shwasa are Dhuma (smoke), 
Raja (dust), Ativyayama (excessive work/exercise), 
Sheetha Sthana Nivasa (residing in cold areas), 
Gurubhojana   (heavy   diet),   Sheetha   Bhojana  (cold  
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food/drinks). These factors cause vitiation of Vata and 
Kapha leading to vitiation of Rasa and impeding the 
functions of Pranavata.[1] 
Tamaka Shwasa has similarity in clinical presentation 
with Bronchial Asthma characterized by intermittent 
airflow obstruction, airway inflammation and 
bronchial hyper responsiveness. Bronchial Asthma 
manifests with difficulty in breathing, cough, 
wheezing, and tightness of chest.[2]  
It is estimated that 300 million people worldwide 
suffer from asthma, among them a tenth of 
population is living in India. The burden of asthma is 
immense; the prevalence of asthma has been 
estimated to range of 2-12% in adults. The world 
health organization estimated that asthma 
contributes to the loss of 15 million disability adjusted 
life.[3] 
Tamaka Shwasa is a Yapya Vyadhi. Kulathadi Kwatha 
and Talisapatradi Churna have been mentioned in 
A B S T R A C T  
Background: Tamaka Shwasa is a Pranavaha Sroto Vikara, with predominant Dosha, Kapha and Vata 
and the site of origin is Pittasthana. The condition has similarity in clinical presentation with Bronchial 
Asthma. It leads to recurrent episodes of breathlessness, wheezing, cough and tightness of chest. 
Shamshodhana and Shamshamana are the two treatment modalities explained in Tamaka Shwasa. 
Objectives: To clinically assess the combined effectiveness of Kulathadi Kwatha and Talisapatradi 
Churna in Tamaka Shwasa. Materials and methods: This study was carried out by 
Shamanaushadhis viz; Kulathadi Kwatha and Talisapatradi Churna in 30 subjects of either sex in 
between the age 18-40 years, for 30 days, followed by follow up on 45th day. Collected data were 
tabulated and analysed using SPSS (Statistical package for social sciences) version 20 by using 
appropriate statistical test. Results: There was statistically significant improvement observed in the 
signs and symptoms of Tamaka Shwasa and Peakflow Meter with the P value <0.05. Conclusion: The 
trial drug Kulathadi Kwatha and Talisapatradi Churna was found beneficial in symptoms of Tamaka 
Shwasa. 
Key words: Tamaka Shwasa, Bronchial Asthma, Kulathadi Kwatha, Talisapatradi Churna, Shamana 
Aushadhis. 
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Shwasa Chikitsa. As per a clinical trial conducted, 
Kulathadi Kwatha is proven to be an effective Yoga 
which has Kaphanishteevana Karma and which 
significantly reduced the other symptoms of Tamaka 
Shwasa within a stipulated time.[4] An antioxidant 
study on Talisapatradi Churna has proven its 
antibacterial and antihistamic activity.[5] Hence, to 
evaluate the combined effectiveness of Kulathadi 
Kwatha and Talisapatradi  Churna and also 
considering the prevalence recurrence and adverse 
effect of Tamaka Shwasa on the quality of life of the 
individual, the following study was conducted. 
OBJECTIVES 
To clinically assess the combined effectiveness of 
Kulathadi Kwatha and Talisapatradi Churna in 
Tamaka Shwasa (Bronchial asthma). 
MATERIALS AND METHODS 
Source of Data 
Subjects who attended the Out - Patient Department 
of Kayachikitsa at Sri Dharmasthala 
Mnajunatheshwara College of Ayurveda and Hospital, 
Hassan. 
Methods of collection of data 
62 subjects were screened and selected based on the 
screening form prepared.  
32 cases were registered and data was collected using 
specially prepared case report form. 
Diagnostic Criteria 
Diagnosis was made on basis of signs and symptoms 
of Tamaka Shwasa [Bronchial asthma] viz. 
Breathlessness (Shwasakrichratha), Wheeze 
(Gurguratwam), Cough (Kasa) and Expectoration 
(Kaphanishteevana). 
Inclusion Criteria 
Patients aged between 18-40 years with features of 
Tamaka Shwasa (bronchial asthma - mild to moderate 
grades as per GINA)[6] with chronicity < 10 years, 
either gender and Patient who are willing to sign in 
informed consent form. 
Exclusion Criteria  
Patients who are known cases of COPD, Pneumonia, 
Tuberculosis, Pleural Effusion, Cardiac Pathology, 
Uncontrolled Diabetes Mellitus, Hypertension, 
Uremia, Acidosis, Malignancy, Head injuries and 
pregnant women/lactating mother were excluded. 
Laboratory Investigation 
Radiological - Chest X- ray (PA view), Absolute 
Eosinophil Count and Peak Expiratory Flow Rate.[7] 
Study Design 
This study was an open label single arm, clinical study 
on 30 subjects of Tamaka Shwasa (Bronchial Asthma) 
selected using convenience sampling technique. 
Intervention 
1. Kulathadi Kwatha[8] 
2. Talisapatradi Churnam[9] 
Source and authentication of raw drug 
Raw drugs were procured and authenticated from 
GMP certified CKKM Pharmacy Trippunithara, Kochi. 
Kulathadi Kwatha was prepared at Sri Dharmasthala 
Manjunatheshwara Teaching Pharmacy, Hassan. 
Talisapatradi Churna was purchased from GMP 
certified Sri Dharmasthala Manjunatheswara 
Ayurveda Pharmacy, Udupi. 
Treatment Plan 
Kulathadi Kwatha: 15 ml tid before food  
Talisapatradi Churna: 4 grams in 3 divided doses after 
food with Madhu as Anupana.[10] 
Duration: 30 days  
Follow up during the treatment: follow up was done 
on 1st, 15th, 30th   
Follow up after the treatment: on 45th day  
Assessment Criteria  
A. Subjective Parameter 
The effect of the therapy was assessed on the basis of 
relief with following signs and symptoms of Tamaka 
Shwasa viz. Shwasakrichrata, Gurguratwam, Kasa, 
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Kaphanishteevanam, Parshwashoola, Aasinolabate 
Soukhyam.  
B. Objective parameters 
Assessment of lung volume was done using GINA 
Scale and Peak expiratory flow rate.  
OBSERVATION 
In the present clinical study 32 subjects were 
registered for observation. Out of 32 subjects 10 
subjects were agriculturist, 17 were from  rural area., 
16 (49.9%) subjects had smoke/dust/perfume, cold 
drinks and frozen foods, cold climate, physical 
exertional activities as aggravating factors, 12 had  
rest, fomentation, change of climate, steam 
inhalation, expectoration as relieving factor, 18 
(56.3%) had Samagni, 21 (65.6%) had Madhyama 
Koshta, 29 (90.6%) had disturbed sleep, 9 (28.1%) had 
a habit of smoking. 
Table 1: Baseline distribution of 32 patients of 
Tamaka Shwasa. 
Lakshana Percent % 
Shwasakruchrata 32 (100%) 
Gurgurakata  32 (100%) 
Kasa  32 (100%) 
Kapha Nishteevana 27 (84.4%) 
Asinolabhate Soukhyam 28 (87.5%) 
Parshwashoola 23 (71.9%) 
Results: A total of 32 subjects of Tamaka Shwasa 
were registered for the study; of which 2 dropped out 
and 30 completed the trial. 
Table 2: Effect of therapy on Shwasakruchrata. 
Shwasakruchrata Mean rank P value 
1st  day  3.85 < 0.005 
15th day  2.90 
30th day  1.60 
45th day  1.65 
Test: Freidman’s test 
Table 3: Effect of therapy on Shwasakruchrata. 
Shwasa 
kruchrata 










22 0 8 30 253.00 -4.35 >0.016 S 
15th-30th 
day  





30 60.00 .000 >0.016 NS 
1st-45th 
day  
29 0 1 30 435.00 -4.77 <0.016 S 
Post hoc-Wilcoxon sign rank test with Bonferroni correction (S - 
Statistically Significant, NS - Not    significant, NR - negative ranks, PR - 
positive ranks, T - ties) 
Table 4: Effect of therapy on Kasa. 
Kasa Mean rank P value 
1st  day  3.88 < 0.005 
15th day  2.85 
30th day  1.75 
45th day  1.52 
Table 5: Effect of therapy on Kasa. 
Kasa Ranks  Sum of 
ranks 
Z P Remarks 






















30 0 0 30 435.00 -
4.889 
<0.016 S 
Post hoc-Wilcoxon sign rank test with Bonferroni correction (S - 
Statistically Significant, NS - Not significant, NR -   negative ranks, PR - 
positive ranks, T - ties) 
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Table 6: Effect of therapy on Gurgurakata. 
Gurgurakata    Mean rank  P value  
1st  day  3.65 < 0.005 
15th day  2.87 
30th day  1.65 
45th day  1.83 
Test: Freidman’s test 
Table 7: Effect of therapy on Gurgurakata. 













-3.69 <.016 S 
15th-30th 
day  



















Post hoc-Wilcoxon sign rank test with Bonferroni correction (S - 
Statistically Significant, NS - Not significant, NR - negative ranks, PR - 
positive ranks, T - ties) 
Table 8: Effect of therapy on Kapha Nishteevana 
Kapha Nishteevana    Mean rank  P value  
1st  day  3.37 < 0.005 
15th day  2.85 
30th day  1.88 
45th day  1.90 
Test: Friedman’s test 

















































Post hoc-Wilcoxon sign rank test with Bonferroni correction (S - 
Statistically Significant, NS - Not significant, NR - negative ranks, PR - 
positive ranks, T - ties) 
Table 10: Effect of therapy on Muhurmuhur Shwasa 
Muhurmuhur Shwasa Mean rank  P value  
1st day  3.50 < 0.005 
15th day  2.67 
30th day  1.82 
45th day  2.02 
Test: Friedman’s Test 
Table 11: Effect of therapy on Muhurmuhur Shwasa 
Muhurmuhur  
Shwasa    
Ranks  Sum 
of 
ranks 
Z P Remarks 
NR PR T Total     





14 1 15 30 112.00 -
3.357 
<0.016 S 
30-45th day  2 5 23 30 8.00 -
1.134 
>0.016 NS 
1st-45th day  22 0 8 30 253.00 -
4.600 
<0.016 S 
Post hoc-Wilcoxon sign rank test with Bonferroni correction (S - Statistically 
Significant, NS - Not significant, NR - negative ranks, PR - positive ranks, T - ties) 
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Table 12: Effect of therapy on  GINA assessment 
severity of Asthma 
GINA severity assessment of 
Asthma 
Mean rank P value 
1st  day  3.58 < 0.005 
15th day  3.05 
30th day  1.63 
45th day  1.73 
Test: Friedman’s Test 
Table 13: Effect  of therapy on GINA assessment 






















































Post hoc-Wilcoxon sign rank test with Bonferroni correction (S - 
Statistically Significant, NS - Not significant, NR - negative ranks, PR - 
positive ranks, T - ties) 
Table 14: Effect of therapy on  Assessment of level of 
asthma control 
Assessment of level of asthma 
control 
Mean rank P value 
1st  day 3.57 < 0.005 
15th day 2.98 
30th day 1.77 
45th day 1.68 
Test: Friedman’s Test   
Table 15: Effect of therapy on Assessment of level of 
Asthma control 
Assessme



















































Post hoc-Wilcoxon sign rank test with Bonferroni correction (S - 
Statistically Significant, NS - Not significant, NR - negative ranks, PR - 
positive ranks, T - ties) 
Table 16: Effect of therapy on Asinolabhate 
Soukhyam and Parshwashoola 
Lakshana 1st day 15th day 30th day 45th day P 
value 
P A P A P A P A 
Asinolabhate 
Soukhyam 
26 4 12 18 1 29 1 29 <0.05 
Parshwashoola 21 9 9 21 2 28 0 30 
P - Present, A - Absent 
There was statistically significant difference in 
Lakshanas like Asinolabhate Soukhyam  & 
Parshwashoola with Cochran’s Q  test at p<0.05. 





1st day 15th day 30th 
day 
45th day N Remarks 
P A P A P A P A 30 S 
26 4 12 18 1 29 1 29 
Sreedevi KS et al. Kulathadi Kwatha and Talisapatradi Churna In Tamaka Shwasa (Bronchial Asthma) 
ISSN: 2456-3110                                                   ORIGINAL ARTICLE July-Aug 2020 
 
Journal of Ayurveda and Integrated Medical Sciences | July - Aug  2020 | Vol. 5 | Issue 4 42 
 
P value 0.001 0.001 0.001 >.001 
P - Present, A - Absent, Test: Mc’nemar Test 
Table 18: Effect of therapy on Parshwashoola 
Parshwa 
Shoola 
1st day 15th day 30th day 45th day N Remarks 
P A P A P A P A 30 S 
21 9 9 21 2 28 0 30 
P value 0.008 0.001 0.001 0.001 
P - Present, A - Absent 
Table 19:  Effect of therapy on PEF 
Parameter 
PEF 

























Test: Repeated measure ANOVA test  













































-.500 125 -.853 -.147 
30th 45th .000 136 -.384 .383 
day  Day 
45th 
Day 
1st Day .800 121 .457 1.143 
15th 
Day 
.500 125 .147 .853 
30th 
Day 
.000 136 -.384 .384 
Repeated measures Anova  BT - before treatment, AT - after treatment, Df 
- degree of freedom 
DISCUSSION 
Effect on Shwasakruchrata: Statistically significant 
improvement was noticed in Shwasakruchrata after 
the treatment. Shwasakruchrata is result of 
Pranavaha Sroto Sankocha and Avarodha, due to Vata 
Prakopa in Pranavaha Srotas & Vata being obstructed 
by Kapha. Kulatha, Nagara, Vasa, Vyaghri & 
Pushkaramula having Laghu Ruksha Guna, Ushna 
Veerya helps in liquefying the Kapha, relieves 
Srotorodha and improves breathing. Talisapatradi 
Churna has Kapha Lekhana & Kapha Vatahara 
properties. It acts as an expectorant, which helped in 
reduction of Shwasakruchrata.[18] 
Effect on Gurghurukata: Gurghurukata was reduced 
by its mean rank statistically significant improvement 
was noticed after treatment. 
Gurghurukata is due to Pranavaha Sroto Avarodha by 
Kapha. It is generated by vibration in the wall of an 
airway on the point of closure due to smooth muscle 
contraction. 
Talisapatradi Churna possess anti-inflammatory, has 
bronchodilator and expectorant actions. It can 
effectively drain out the mucus and reduce airway 
resistance.[19] 
Effect on Kasa and Kapha Nishteevana: Statistically 
significant improvement was noticed in Kasa and 
Kapha Nishteevana after treatment. Kasa is an effort 
to expel the Malaroopi Kapha secreted in the 
Pranavaha Srotas. Talisapatradi Churna having Katu 
Rasa, Laghu Ruksha Guna, Ushna Veerya & Kapha 
Vatahara properties facilitates liquefaction of the 
mucus and thus helped in reduction of Kasa & Kapha 
Nishteevana.[20] 
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Effect on Muhurmuhur Shwasa: The symptom was 
reduced in its mean rank & statistically significant 
improvement was noticed. Due to Ruksha Guna, 
Ushna Veerya of Talisapatradi  Churna and Kulathadi 
Kwatha, there was reduction in Kapha causing relief in 
symptom of Muhurmuhur Shwasa.[21] 
Effect on Asinolabhate Soukhyam: Statistically 
significant improvement was noticed in Asinolabhate 
Soukhyam after treatment. An individual suffering 
with Tamaka Shwasa experiences difficulty in 
breathing in supine position and relief while sitting. 
This can be explained as the increased broncho 
constriction due Kapha Avarodha causing 
Pratilomagati of Pranavayu additional to physiological 
diaphragmatic pressure on lungs in supine position.  
Ushna Teekshna Katu properties of drugs in 
Talisapatradi  Churna helps in reduction in production 
of Kapha and increases elimination of Kapha. Thus 
clearing the airway obstruction and Vata Anulomana 
which inturn reduces the broncho constriction and 
dyspnea.[22] 
Effect on Parshwashoola: Statistically significant 
improvement was noticed in Parshwashoola by its 
mean after treatment. Due to aggravation in Vata and 
Kapha, patient experiences repeated cough and 
breathing difficulty, in turn causes pain in Parshwa 
Bhaga.  
The Teeksha Guna, Ushna Veerya & Kapha Vata 
Shamaka properties of Talisadpatradi Churna and 
Kulathadi Kwatha helped in reduction of cough, 
thereby relieved Parshwashoola.[23] 
Effect on Gina Assessment Scale: Significant 
improvement in assessment of level of asthma control 
and in severity of asthma control was noticed after 
treatment. Laghu Ruksha, Teekshna Guna, Ushna 
Veerya & Kapha Vatahara properties of Kulathadi 
Kwatha and Talisapatradi  Churna helped in relieving 
symptoms of Tamaka Shwasa. 
Effect on Peak Expiratory Flow Rate: Statistically 
significant reduction in Peak Expiratory Flow was 
observed before and after the treatment. Kapha 
Vilayana property of the Kulathadi Kwatha and 
Talisapatradi Churna enhanced the normal Gati of 
Vata. It showed significant reduction in the airway 
obstruction and relief from symptoms of Shwasa 
Kruchrata, Gurghurukata & Kasa. Thus, there was 
improvement in the values of peak expiratory flow 
rate. 
CONCLUSION 
The trial drug Kulathadi Kwatha and Talisapatradi 
Churna was found beneficial in symptoms of Tamaka 
Shwasa. Statistically significant improvement was 
observed in primary outcome measures like, 
Shwasakruchrata, Gurgurata, Kasa, Kaphashteevana, 
Asinolabhate Soukhyam & Parshwashoola. The 
assessment of severity of asthma and level of asthma 
control as per GINA scale showed marked 
improvement in all parameters like day time 
symptoms, exacerbations, nocturnal symptoms and 
limitations of activities after treatment. Statistically 
significant improvement was noticed in secondary 
outcome measures Peak expiratory flow rate. 
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